Form 8-K - Current report:
SEC Accession No. 0001411690-25-000073
Filing Date
2025-06-13
Accepted
2025-06-13 16:24:27
Documents
12
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20250610.htm   iXBRL 8-K 40575
  Complete submission text file 0001411690-25-000073.txt   156946

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20250610.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20250610_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20250610_pre.xml EX-101.PRE 12516
15 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20250610_htm.xml XML 3157
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 251046946
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)